Image Credit: Cleveland Announcement The genialis, a leading RNA biomarker company, has entered a clinical partnership with the Cleveland Clinic, one of the leading academic medical centers, to establish AI-powered tools that will help doctors address the prominent treatment options for pancreat...
Image Credit: Bial Announcement Bial, a leading innovation-centric biopharmaceutical company targeting rare diseases and neurosciences, proudly mentioned its key progress in its current ACTIVATE (NCT05819359), phase 2 clinical trial examining the tolerability, efficacy, safety, pharmacokin...
Image Credit: Fierce Healthcare Announcement Hackensack Meridian Health, a non-profit healthcare US-based organization, has entered a partnership with SpotiEarly for detecting early cancer with the help of trained dogs and AI potential. The dogs are capable of addressing fluctuation in odo...
Announcement Alpha Cognition Inc., a known marketed stage biopharmaceutical company committed to discovering innovative treatments for neurodegenerative diseases, confirmed its proposed offering and sale of common shares to a few investors, and pre-funded warrants to buy its common shares i...
Image Credit: Drug Discovery and Development Announcement OS Therapies Inc., a leading antibody drug conjugate and clinical-stage cancer immunotherapy biotechnology company has informed a regulatory update on its further plans for completing its marketing authorizations in the united kingdom (UK...
Image Credit: Mint Announcement Pfizer’s CEO, Albert Bourla, appreciated tariffs, calling it a deal through which the company will provide drugs on a corner to be launched website known as ‘trumpRx’. Yesterday, on Tuesday, at the press conference in the Oval Office, Presi...
Image Credit: STAT News Announcement In the time of great awareness and geopolitical imbalance, covering national health security has well explained the necessity of reviving the production of responsive pharmaceutical ingredients, which cannot be inflated. The Olin Business School at Wash...
Image Credit: Yahoo Finance Announcement Recode Therapeutics, a leading clinical-stage genetics medicines company utilizing tissue-specific delivery to strengthen the next generation of gene correction and mRNA therapeutics, has closed above $29 million in additional financing. The company...
Image Credit: Pancreatic Cancer Action Network Announcement Oncolytics Biotech Inc., a leading clinical-stage immunotherapy company, is establishing pelareorep, which has prompted an update on its offered design of its intended registration-directed clinical trial in the first-line pancreatic du...
Image Credit: Healthtech Magazine Announcement Most healthcare companies are approaching AI for larger processes. Shifting from distinct operations, AI is now considered to play a crucial role in the whole production process. Artificial intelligence is already a developed area of biopharma...
